Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy

American Journal of Hematology

Fecha de publicación: 28 February 2020

DOI: https://doi.org/10.1002/ajh.25769

Autores: Guillermo Montalban‐Bravo, Rashmi Kanagal‐Shamanna, Caleb A. Class, Koji Sasaki, Farhad Ravandi, Jorge E. Cortes, Naval Daver, Koichi Takahashi, Nicholas J. Short, et al.

Background: Acute myeloid leukemia with myelodysplasia‐related changes (AML‐MRC) is a heterogeneous disorder defined by multilineage dysplasia, myelodysplastic syndrome (MDS)‐related karyotype, or history of prior MDS.